Lipid Composition for FAS-201Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.4851.2099
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.21 mg/vial100
Lipid Composition for FAS-202Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.3501.0990
L-alpha-phosphatidylcholine0.1350.109
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.20 mg/vial100
Lipid Composition for FAS-203Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.2000.9780
L-alpha-phosphatidylcholine0.2850.2219
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.20 mg/vial100
Lipid Composition for FAS-204Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.0500.8570
L-alpha-phosphatidylcholine0.4350.3429
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.20 mg/vial100
Lipid Composition for FAS-205Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.9000.7360
L-alpha-phosphatidylcholine0.5850.4539
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.19 mg/vial100
Lipid Composition for FAS-206Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.7500.6050
L-alpha-phosphatidylcholine0.7350.5749
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.18 mg/vial100
Lipid Composition for FAS-207Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.6000.4840
L-alpha-phosphatidylcholine0.8850.6859
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.17 mg/vial100
Lipid Composition for FAS-208Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.4500.3630
L-alpha-phosphatidylcholine1.0350.8069
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.17 mg/vial100
Lipid Composition for FAS-209Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.3000.2420
L-alpha-phosphatidylcholine1.1850.9179
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.16 mg/vial100
Lipid Composition for FAS-210Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.1500.1210
L-alpha-phosphatidylcholine1.3351.0389
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(7-nitro-2-1,3-benzoxadiazol-4-yl) (ammonium salt) (NBD PE)0.0150.011
Total1.500 µmol/vial1.16 mg/vial100
Lipid Composition for FAS-211Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.4851.2099
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.011
Total1.500 µmol/vial1.21 mg/vial100
Lipid Composition for FAS-212Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.3501.0990
L-alpha-phosphatidylcholine0.1350.109
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.21 mg/vial100
Lipid Composition for FAS-213Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.2000.9780
L-alpha-phosphatidylcholine0.2850.2219
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.21 mg/vial100
Lipid Composition for FAS-214Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine1.0500.8570
L-alpha-phosphatidylcholine0.4350.3429
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.21 mg/vial100
Lipid Composition for FAS-215Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.9000.7360
L-alpha-phosphatidylcholine0.5850.4539
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.20 mg/vial100
Lipid Composition for FAS-216Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.7500.6050
L-alpha-phosphatidylcholine0.7350.5749
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.19 mg/vial100
Lipid Composition for FAS-217Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.6000.4840
L-alpha-phosphatidylcholine0.8850.6859
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.18 mg/vial100
Lipid Composition for FAS-218Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.4500.3630
L-alpha-phosphatidylcholine1.0350.8069
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.18 mg/vial100
Lipid Composition for FAS-219Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.3000.2420
L-alpha-phosphatidylcholine1.1850.9179
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.17 mg/vial100
Lipid Composition for FAS-220Amount (µmol/vial)Amount (mg/vial)Molar Ratio Percentage
L-alpha-phosphatidylserine0.1500.1210
L-alpha-phosphatidylcholine1.3351.0389
1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) (Rhod PE)0.0150.021
Total1.500 µmol/vial1.17 mg/vial100
Recent Clients